A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes
Public ClinicalTrials.gov record NCT02785120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Study to Evaluate the Efficacy and Safety of TF0023 Spray Versus Placebo in Functional Improvement of Patients With Ischemic Strokes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase 2, multicenter, randomized, double-blind (within dose), placebo controlled, parallel-group, dose-range finding study to evaluate the efficacy and safety of TF0023 spray versus placebo in functional improvement of patients with ischemic strokes under standard of care.
Study identification
- NCT ID
- NCT02785120
- Recruitment status
- Suspended
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 225 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2017
- Primary completion
- Sep 30, 2024
- Completion
- Nov 30, 2024
- Last update posted
- Jan 4, 2024
2017 – 2024
United States locations
- U.S. sites
- 24
- U.S. states
- 16
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Four Peaks Neurology | Scottsdale | Arizona | 85258 | — |
| General Neuronology | Scottsdale | Arizona | 85258 | — |
| Colorado Springs Neurological Associates | Colorado Springs | Colorado | 80907 | — |
| CarePoint, P.C. dba Blue Sky Neurology | Englewood | Colorado | 80113 | — |
| Tenet South Florida / Delray Medical Center | Delray Beach | Florida | 33484 | — |
| The Neurology Research Group | Miami | Florida | 33176 | — |
| Florida Hospital of Orlando | Orlando | Florida | 32803 | — |
| Florida Hospital Orlando | Orlando | Florida | 32803 | — |
| Central Baptist Hospital | Lexington | Kentucky | 40503 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Midwest Physicians Group | Kansas City | Missouri | 64132 | — |
| Washington University School of Medicine - Center for Advanced Medicine (CAM) - Neuroscience Center | St Louis | Missouri | 63110-1032 | — |
| Renown Medical Group | Reno | Nevada | 89502 | — |
| Hackensack Neurology Group | Hackensack | New Jersey | 07601 | — |
| Icahn School of Medicine at Mount Sinai (ISMMS) - Institute for Critical Care Medicine | New York | New York | 10029-6508 | — |
| Neurology and Neuroscience Associates | Akron | Ohio | 44320 | — |
| The Ohio State University Wexner Medical Center (OSUWMC) - Neurovascular Stroke Center | Columbus | Ohio | 43210 | — |
| Providence Stroke Center | Portland | Oregon | 97225-6652 | — |
| Neurovascular Associates of Abington | Abington | Pennsylvania | 19001 | — |
| Coastal Nurology | Port Royal | South Carolina | 29935 | — |
| Chattanooga Neurology Associates - Memorial Office | Chattanooga | Tennessee | 37404-1154 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Neurology Associates of Arlington, PA | Mansfield | Texas | 76063 | — |
| VCU Medical Center | Richmond | Virginia | 23298 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02785120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 4, 2024 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02785120 live on ClinicalTrials.gov.